{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:15:25Z","timestamp":1790111725815,"version":"4.0.1"},"reference-count":14,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2017,10,15]],"date-time":"2017-10-15T00:00:00Z","timestamp":1508025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Cosmetic Dermatology"],"published-print":{"date-parts":[[2018,6]]},"abstract":"<jats:title>Summary<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Vitiligo is one of the commonest pigmentary disorders characterized by destruction of melanocytes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>To evaluate the efficacy of topical bimatoprost ophthalmic solution in stable facial vitiligo.<\/jats:p><\/jats:sec><jats:sec><jats:title>Material and methods<\/jats:title><jats:p>Eight cases of stable facial vitiligo were treated with bimatoprost 0.03% ophthalmic solution once daily for 12 weeks. Photographic records were taken at 2 weeks follow\u2010up along with dermoscopic (Polarized, 10\u00d7) evaluation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Four cases had excellent repigmentation, two cases had partial repigmentation and two cases had poor response.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Bimatoprost seems to be promising in treating stable vitiligo but large\u2010scale studies are required.<\/jats:p><\/jats:sec>","DOI":"10.1111\/jocd.12443","type":"journal-article","created":{"date-parts":[[2017,10,16]],"date-time":"2017-10-16T04:23:41Z","timestamp":1508127821000},"page":"437-440","source":"Crossref","is-referenced-by-count":25,"title":["Bimatoprost ophthalmic solution in facial vitiligo"],"prefix":"10.1111","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6010-3771","authenticated-orcid":false,"given":"Abhijeet K.","family":"Jha","sequence":"first","affiliation":[{"name":"Department of Skin &amp; V.D Patna Medical College &amp; Hospital Patna India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smita","family":"Prasad","sequence":"additional","affiliation":[{"name":"Department of Skin &amp; V.D Patna Medical College &amp; Hospital Patna India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Sinha","sequence":"additional","affiliation":[{"name":"Department of Dermatology All India Institute of medical sciences Patna India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,10,15]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707434"},{"key":"e_1_2_9_3_1","volume-title":"Goodman & Gilman's The Pharmacological Basis of Therapeutics","author":"Smyth EM","year":"2006"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6257(01)00224-7"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6257(02)00327-2"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2008.08.001"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.123.11.1541"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03346.x"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2007.128454"},{"key":"e_1_2_9_10_1","first-page":"350","article-title":"Three cases of vitiligo showing response to application of latanoprost","volume":"48","author":"Noh S","year":"2010","journal-title":"Korean J Dermatol"},{"key":"e_1_2_9_11_1","first-page":"703","article-title":"Bimatoprost 0.03% Solution for the Treatment of Nonfacial Vitiligo","volume":"15","author":"Grimes PE","year":"2016","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13176"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/ced.12904"},{"key":"e_1_2_9_14_1","unstructured":"Allergan Inc.Lumigan[package insert].Irvine CA:Allergan Inc.;2006."},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.120.10.1286"}],"container-title":["Journal of Cosmetic Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjocd.12443","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jocd.12443","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T17:31:26Z","timestamp":1695490286000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jocd.12443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,15]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["10.1111\/jocd.12443"],"URL":"https:\/\/doi.org\/10.1111\/jocd.12443","archive":["Portico"],"relation":{},"ISSN":["1473-2130","1473-2165"],"issn-type":[{"value":"1473-2130","type":"print"},{"value":"1473-2165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,15]]}}}